<?xml version = '1.0' encoding = 'UTF-8'?><STUDY_SET>
   <STUDY alias="ena-STUDY-CURIE-22-11-2016-13:15:03:011-1876" center_name="CURIE" broker_name="EGA" accession="ERP019959">
      <IDENTIFIERS>
         <PRIMARY_ID>ERP019959</PRIMARY_ID>
         <SUBMITTER_ID namespace="CURIE">ena-STUDY-CURIE-22-11-2016-13:15:03:011-1876</SUBMITTER_ID>
      </IDENTIFIERS>
      <DESCRIPTOR>
         <STUDY_TITLE>Methylation of Ewing sarcoma tumors (ICGC)</STUDY_TITLE>
         <STUDY_ABSTRACT>Ewing sarcoma (ES) is a primary bone tumor initiated by an EWSR1-ETS gene fusion. To characterize the methylation of Ewing sarcoma, reduced representation bisulfite sequencing was performed.</STUDY_ABSTRACT>
         <STUDY_DESCRIPTION>Ewing sarcoma (ES) is a primary bone tumor initiated by an EWSR1-ETS gene fusion. To characterize the methylation of Ewing sarcoma, reduced representation bisulfite sequencing was performed.</STUDY_DESCRIPTION>
         <CENTER_PROJECT_NAME>Methylation of Ewing sarcoma tumors (ICGC)</CENTER_PROJECT_NAME>
         <STUDY_TYPE existing_study_type="Other"/>
      </DESCRIPTOR>
      <STUDY_LINKS>
         <STUDY_LINK>
            <XREF_LINK>
               <DB>PUBMED</DB>
               <ID>28134926</ID>
            </XREF_LINK>
         </STUDY_LINK>
      </STUDY_LINKS>
   </STUDY>
</STUDY_SET>